TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹14,798 Cr | ₹3,026 Cr | ₹3,937 Cr | ₹5,297 Cr | ₹4,018 Cr |
What is the latest Total Debt ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹14,798 Cr |
| Mar2025 | ₹3,026 Cr |
| Mar2024 | ₹3,937 Cr |
| Mar2023 | ₹5,297 Cr |
| Mar2022 | ₹4,018 Cr |
How is Total Debt of TORRENT PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹14,798 Cr | 389.02 | |
| Mar2025 | ₹3,026 Cr | -23.15 | |
| Mar2024 | ₹3,937 Cr | -25.67 | |
| Mar2023 | ₹5,297 Cr | 31.84 | |
| Mar2022 | ₹4,018 Cr | - | |
Compare Total Debt of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹183,468.8 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
| MANKIND PHARMA | ₹92,852.5 Cr | -0.8% | -6.3% | -12.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -2.2% |
-1.5% |
35% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses